Literature DB >> 28818874

Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.

Alain Michils1, Amaryllis Haccuria1, Sebastien Michiels1, Alain Van Muylem2.   

Abstract

Changes in airway calibre have the potential to modify exhaled nitric oxide fraction (FENO) values and could hamper how FENO captures changes in asthma control. Here, our objective was to assess whether forced expiratory volume in 1 s (FEV1) variations alter the ability of FENO to reflect asthma control.FENO, asthma control (Asthma Control Questionnaire (ACQ)) and FEV1 were measured at least two times in 527 patients during 1819 pairs of visits. Determinants of FENO-ACQ discordance probability were evaluated through a logistic regression analysis. The effectiveness of FENO at capturing either asthma control worsening or improvement between two visits was then assessed by undertaking a stratified receiver operating characteristic curves analysis.When FEV1 and FENO change in the same direction, the odds of FENO-ACQ being discordant are multiplied by 3 (p<0.001). The area under the curve values were 0.765 (95% CI 0.713-0.805) (improvement; p<0.001) and 0.769 (95% 0.706-0.810) (worsening; p<0.001) or 0.590 (95% 0.531-0.653) (improvement; p=0.001) and 0.498 (95% 0.416-0.567) (worsening; p=0.482) when FEV1 and FENO changed in the opposite or same direction, respectively.The manner in which FENO and FEV1 vary concomitantly when asthma control changes determines the ability of FENO to capture this change: parallel or opposite changes in FEV1 and FENO either decrease or increase this ability to capture asthma control changes.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28818874     DOI: 10.1183/13993003.00392-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  30 in total

1.  Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.

Authors:  J D Leuppi; C M Salome; C R Jenkins; S D Anderson; W Xuan; G B Marks; H Koskela; J D Brannan; R Freed; M Andersson; H K Chan; A J Woolcock
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies.

Authors:  P G Gibson
Journal:  Clin Exp Allergy       Date:  2009-02-25       Impact factor: 5.018

3.  Exhaled nitric oxide levels during treatment in patients hospitalized with asthma.

Authors:  Alan P Baptist; Bhavish Shah; Yun Wang; Joel Ager; M Safwan Badr
Journal:  Allergy Asthma Proc       Date:  2008 Mar-Apr       Impact factor: 2.587

4.  Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes.

Authors:  Amaryllis Haccuria; Alain Michils; Sébastien Michiels; Alain Van Muylem
Journal:  J Allergy Clin Immunol       Date:  2014-02-09       Impact factor: 10.793

5.  The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.

Authors:  M A Berry; D E Shaw; R H Green; C E Brightling; A J Wardlaw; I D Pavord
Journal:  Clin Exp Allergy       Date:  2005-09       Impact factor: 5.018

6.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.

Authors:  Andrew D Smith; Jan O Cowan; Karen P Brassett; G Peter Herbison; D Robin Taylor
Journal:  N Engl J Med       Date:  2005-05-24       Impact factor: 91.245

7.  Acute and chronic effects of cigarette smoking on exhaled nitric oxide.

Authors:  S A Kharitonov; R A Robbins; D Yates; V Keatings; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

8.  The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.

Authors:  Dominick E Shaw; Mike A Berry; Mike Thomas; Ruth H Green; Chris E Brightling; Andrew J Wardlaw; Ian D Pavord
Journal:  Am J Respir Crit Care Med       Date:  2007-05-11       Impact factor: 21.405

9.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Authors:  Kian Fan Chung; Sally E Wenzel; Jan L Brozek; Andrew Bush; Mario Castro; Peter J Sterk; Ian M Adcock; Eric D Bateman; Elisabeth H Bel; Eugene R Bleecker; Louis-Philippe Boulet; Christopher Brightling; Pascal Chanez; Sven-Erik Dahlen; Ratko Djukanovic; Urs Frey; Mina Gaga; Peter Gibson; Qutayba Hamid; Nizar N Jajour; Thais Mauad; Ronald L Sorkness; W Gerald Teague
Journal:  Eur Respir J       Date:  2013-12-12       Impact factor: 16.671

10.  Modeling of the Nitric Oxide Transport in the Human Lungs.

Authors:  Cyril Karamaoun; Alain Van Muylem; Benoît Haut
Journal:  Front Physiol       Date:  2016-06-28       Impact factor: 4.566

View more
  1 in total

1.  Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC).

Authors:  Enrico Heffler; Giovanna Elisiana Carpagnano; Elisabetta Favero; Giuseppe Guida; Mauro Maniscalco; Andrea Motta; Giovanni Paoletti; Giovanni Rolla; Eugenio Baraldi; Vincenza Pezzella; Giorgio Piacentini; Stefano Nardini
Journal:  Multidiscip Respir Med       Date:  2020-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.